Antibody-based HIV-1 vaccines: recent developments and future directions.
Duke University Medical Center, Durham, North Carolina, United States of America. monte@duke.edu
David
D
Montefiori
Quentin
Q
Sattentau
Jorge
J
Flores
José
J
Esparza
John
J
Mascola
D016915:AIDS Vaccines / Q000737:chemistry / Q000276:immunology*; D000818:Animals; D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D015195:Drug Design; D018604:Epitope Mapping; D015483:HIV Antibodies / Q000097:blood* / Q000737:chemistry; D015488:HIV Antigens / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D009500:Neutralization Tests / Q000592:standards; D011487:Protein Conformation; D011786:Quality Control; D011961:Receptors, Fc / Q000276:immunology; D015203:Reproducibility of Results
D016915:AIDS Vaccines; D015483:HIV Antibodies; D015488:HIV Antigens; D011961:Receptors, Fc; D003165:Complement System Proteins